Chemical crosslinking of the subunits of HIV-1 reverse transcriptase

Protein Science

Volumn 5, Issue 2, 1996, Pages 278-286

  Debyser, Zeger ^a   De Clercq, Erik ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

chemical crosslinking; human immunodeficiency virus type 1; oligomerization; reverse transcriptase; RT inhibitors

Indexed keywords

RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ARTICLE; DIMERIZATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME INHIBITOR COMPLEX; ENZYME SUBUNIT; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIORITY JOURNAL; PROTEIN CROSS LINKING;

EID: 0030041881     PISSN: 09618368     EISSN: None     Source Type: Journal    
DOI: 10.1002/pro.5560050212     Document Type: Article

References (38)

1. Baillon JG, Nashed NT, Kumar A, Wilson SH, Jerina DM. 1991. A leucine zipper-like motif may mediate HIV reverse transcriptase subunit binding. New Biol 3:1015-1019.
2. Bathurst IC, Moen LK, Lujan MA, Gibson HL, Feucht PH, Pichuantes S, Craik CS, Santi DV, Barr PJ. 1990. Characterization of the human immunodeficiency virus type 1 reverse transcriptase produced in yeast. Biochem Biophys Res Commun 171:589-595.
3. Becerra SP, Kumar A, Lewis MS, Wide SG, Abbotts J, Karawya EM, Hughes SH, Shiloach J, Wilson SH. 1991. Protein-protein interactions of HIV-1 reverse transcriptase: Implications of central and C-terminal regions in subunit binding. (Lewis MS. Appendix: Ultracentrifuge analysis of a mixed association.) Biochemistry 30:11707-11719.
4. Bhikhabhai R, Jackson T, Unge T, Strandberg B, Carlsson T, Lövgren S. 1992. Purification, characterization and crystallization of recombinant HIV-1 reverse transcriptase. J Chromatogr 604:157-170.
5. Chandra A, Gerber T, Kaul S, Wolf C, Demirhan I, Chandra P. 1986. Biochemical heterogeneity of reverse transcriptase purified from the AIDS virus. FEBS Lett 200:321-323.
6. Cook PR. 1993. A model for reverse transcription by a dimeric enzyme. J Gen Virol 74:691-697.
7. Davies GE, Stark GR. 1970. Use of dimethylsuberimidate, a crosslinking reagent, in studying the subunit structure of oligomeric proteins. Proc Natl Acad Sci USA 66:651-656.
8. Debyser Z. 1994. Studies on HIV-1 reverse transcriptase and reverse transcriptase inhibitors. In: Viral DNA synthesis. Leuven University Press. Acta Biomedica Lovaniensia 77:43-46.
9. Debyser Z, Pauwels R, Andries K, Desmyter J, Engelborghs Y, Janssen PAJ, De Clercq E. 1992. Allosteric inhibition of HIV-1 reverse transcriptase by TIBO compounds. Mol Pharmacol 41:203-208.
10. Debyser Z, Pauwels R, Andries K, Desmyter J, Kukla M, Janssen PAJ, De Clercq E. 1991. An antiviral target on reverse transcriptase of human immunodeficiency virus type 1 revealed by tetrahydroimidazo[4,5,1-jk] [1,4]benzodiazepin-2(1H)one and -thione derivatives. Proc Natl Acad Sci USA 88:1451-1455.
11. De Clercq E. 1992. HIV inhibitors targeted at the reverse transcriptase. AIDS Res Human Retrovir 8:119-134.
12. Di Marzo-Véronese F, Copeland TD, DeVico AL, Rahman R, Oroszlan S, Gallo RC, Sarngadharan MG. 1986. Characterization of highly immunogenic p66/p51 as the reverse transcriptase of HTLV-III/LAV. Science 231:1289-1291.
13. Ding J, Jacobo-Molina A, Tantillo C, Lu X, Nanni RG, Arnold E. 1994. Buried surface analysis of HIV-1 reverse transcriptase p66/p51 heterodimer and its interaction with dsDNA template/primer. J Mol Recognition 7:157-161.
14. Divita G, Müller B, Immendörfer U, Gautel M, Rittinger K, Restle T, Goody RS. 1993. Kinetics of interaction of HIV reverse transcriptase with primer/template. Biochemistry 32:7966-7971.
15. Divita G, Restle T, Goody RS, Chermann JC, Baillon JG. 1994. Inhibition of human immunodeficiency virus type 1 reverse transcriptase using synthetic peptides derived from the connection domain. J Biol Chem 269: 13080-13083.
16. Goel R, Beard WA, Kumar A, Casas-Finet JR, Strub MP, Stahl SJ, Lewis MS, Bebenek K, Becerra SP, Kunkel TA, Wilson SH. 1993. Structure/function studies of HIV-1 reverse transcriptase: Dimerization-defective mutant L289K. Biochemistry 32:13012-13018.
17. Goff SP. 1990. Retroviral reverse transcriptase: Synthesis, structure and function. J AIDS 3:817-831.
18. Hansen J, Schultze T, Mellert W, Moelling K. 1988. Identification and characterization of HIV-specific RNase H by monoclonal antibody. EMBO J 7:239-243.
19. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M. 1995. Rapid turnover of plasma virions and CD4 lymphocyte in HIV-1 infection. Nature 373:123-126.
20. Hoffman AD, Banapour B, Levy JA. 1985. Characterization of the AIDS-associated retrovirus reverse transcriptase and optimal conditions for its detection in virions. Virology 147:326-335.
21. Jacobo-Molina A, Arnold E. 1991. HIV reverse transcriptase structurefunction relationships. Biochemistry 30:6351-6361.
22. Jacobo-Molina A, Ding J, Nanni R, Clark AD, Lu X, Tantillo C, Williams R, Kamer G, Ferris AL, Clark P, Hizi A, Hughes S, Arnold E. 1993. Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 Ȧ resolution shows bent DNA. Proc Natl Acad Sci USA 90:6320-6324.
23. Johnson MA, McClure MA, Feng DF, Gray J, Doolittle RF. 1986. Computer analysis of retroviral pol genes: Assignment of enzymatic functions to specific sequences and homologies with nonviral enzymes. Proc Natl Acad Sci USA 83:7648-7452.
24. 138→Lys on the p51 subunit. J Biol Chem 269:25255-25258.
25. Kohlstaedt LA, Wang J, Friedman JM, Rice PA, Steitz TA. 1992. Crystal structure at 3.5 Ȧ resolution of HIV-1 reverse transcriptase complexed with an inhibitor. Science 255:1783-1790.
26. Larder BA. 1993. Inhibitors of HIV reverse transcriptase as antiviral agents and drug resistance. In: Skalka AM, Goff SP, eds. Reverse transcriptase. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press. pp 205-222.
27. Lebowitz J, Kar S, Braswell E, McPherson S, Richard DL. 1994. Human immunodeficiency virus-1 reverse transcriptase heterodimer stability. Protein Sci 3:1374-1382.
28. Le Grice SFJ. 1993. Human immunodeficiency virus reverse transcriptase. In: Skalka AM, Goff SP, eds. Reverse transcriptase. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press. pp 163-191.
29. Lightfoote NN, Coligon JE, Folks TM, Fauci AS, Martin MA, Venkatesan S. 1986. Structural characterization of reverse transcriptase and endonuclease polypeptides of the acquired immunodeficiency syndrome retrovirus. J Virol 60:771-775.
30. Merluzzi VJ, Hargrave KD, Labadia M, Grozinger K, Skoog M, Wu JC, Shih CK, Eckner E, Hattox S, Adams J, Rosenthal AS, Faanes R, Eckner RJ, Koup RA, Sullivan JL. 1990. Inhibition of HIV-1 replication by a nonnucleoside reverse transcriptase inhibitor. Science 250:1411-1413.
31. Pantaleo G, Graziosi C, Demarest JF, Butini L, Montroni M, Fox CH, Orenstein JM, Kotler DP, Fauci AS. 1993. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 362:355-358.
32. Patel SS, Hingorani MM. 1993. Oligomeric structure of bacteriophage T7 DNA primase/helicase proteins. J Biol Chem 268:10668-10675.
33. Pauwels R, Andries K, Desmyter J, Schols D, Kukla MJ, Breslin HJ, Raeymaeckers A, Van Gelder J, Woestenborghs R, Heykants J, Schellekens K, Janssen MAC, De Clercq E, Janssen PAJ. 1990. Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives. Nature 343:470-474.
34. Peters K, Richards FM. 1977. Chemical crosslinking: Reagents and problems in studies of membrane structure. Annu Rev Biochem 46:523-551.
35. Restle T, Muller B, Goody RS. 1990. Dimerization of human immunodeficiency virus type 1 reverse transcriptase. J Biol Chem 265:8986-8988.
36. Unge T, Ahola H, Bhikhabhai R, Backbro K, Lövgren S, Fenyö EM, Honigman A, Panet A, Gronowitz JS, Strandberg B. 1990. Expression, purification, and crystallization of the HIV-1 reverse transcriptase (RT). AIDS Res Human Retrovir 6:1297-1303.
37. Vriend G. 1990. A molecular modeling and drug design program. J Mol Graph 8:52-56.
38. Wei X, Ghosh SK, Taylor ME, Johnson VA, Emini EA, Deutsch P, Lifson JD, Bonhoeffer S, Nowak MA, Hahn BH, Saag MS, Shaw GM. 1995. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373:117-122.